Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sichuan Kelun’s Purchase of 20% Stake in Lijun Pharma is Off

publication date: Nov 1, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sichuan Kelun Pharmaceutical will not acquire a 20% stake in Lijun International Pharma (HK: 2005), a transaction that was previously announced in December of last year. No reason for the reversal was given. At the time of the original announcement, Kelun said it would pay $135 million to buy the stake from two major Lijun shareholders. More details....

Stock Symbol: (SHE: 002422)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...